Summary

The Vancomycin Market is expected to grow at a strong CAGR of around 5% during the forecast period. Vancomycin is an essential antibiotic medication that is highly in demand globally due to its effectiveness against severe bacterial infections caused by bacterial infection. As antibiotic resistance continues to rise, vancomycin remains a crucial treatment option for many infectious diseases. Furthermore, the growing incidence of healthcare-associated infections and the aging population's vulnerability to infections are also contributing factors to the high demand for vancomycin. Despite concerns about potential side effects and the availability of alternative treatment options, efforts to improve the drug's safety and formulation, along with the ongoing need for effective antibiotic treatment, are expected to maintain the growth trajectory of the vancomycin market.

Vancomycin works by inhibiting the bacterial cell wall's synthesis, which prevents the bacteria from multiplying and spreading. Furthermore, the rising demand for antibiotics globally and the increasing prevalence of infections by several pharmaceutical companies manufacturing and distributing vancomycin globally will drive the growth of the market.

Some of the major players operating in the market include Pfizer Inc.; Lilly; Viamericas Corporation; Alvogen; Aphios Corporation; Enanta Pharmaceuticals, Inc.; LEGOCHEM BIOSCIENCES, Inc.; LYTIX BIOPHARMA AS; MGB Biopharma; Microbiotix Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report
“Amongst type, the daptomycin segment held a dominating share of the market in 2021.”
Based on type, the market is segmented into daptomycin, linezolid, quinupristin, ampicillin, chloramphenicol, and others. Amongst these, the daptomycin category dominated the market in 2021. This is due to the increasing prevalence of antibiotic-resistant infections, favorable regulatory environment, increasing demand for novel antibiotics, and rise in hospital-acquired infections. For instance, The Centers for Disease Control and Prevention (CDC) estimates that HAIs cause an estimated 1.7 million infections and 99,000 deaths annually in American hospitals alone.

“Amongst application, lung infections held the majority share of the market in 2021.”
By application, the market is bifurcated into sepsis, lung infection, skin soft tissue infection, colitis & intestinal inflammation, and others. Among these, the lung infection category captured the majority share of the vancomycin market in 2021. This is mainly due to the rising cases of pneumonia, increasing incidence of hospital-acquired infections and the rise of drug-resistant bacterial infections have led to an increased demand for vancomycin. For instance, as per UNICEF, around 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year diagnosed globally.

“APAC is expected to grow at the fastest rate in 2021”
APAC is expected to grow at the fastest rate in 2021 due to the rising incidence of bacterial infections, increasing awareness about infectious diseases, and the growing use of vancomycin in hospitals and other healthcare facilities. The APAC region is also witnessing an increase in the number of geriatric patients, who are more susceptible to infections, and this is expected to further boost the demand for vancomycin. Moreover, the increasing prevalence of antibiotic-resistant bacteria is likely to drive the demand for vancomycin, which is an effective treatment option for resistant strains of bacteria.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:
The global Vancomycin Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

ページTOPに戻る

Table of Contents